• (PLX AI) – Merck KGaA shares rose nearly 2% in morning trading after the drugmaker issued new targets for the next 4 years that were higher than expected.
  • • The company aims for group sales of around EUR 25 billion in 2025, above consensus of EUR 24 billion
  • • Life Science organic growth targets are 7-10%, above consensus at 6.5%
  • • Healthcare targets mid-single-digit organic sales growth, with consensus at 5.5%
  • • Electronics targets organic growth 3-6%, above consensus of 4%
  • • Recent months have seen a significant re-rating of quality compounders in the EU pharma sector, including Merck KGaA, and momentum may continue, Bank of America said, reiterating a neutral recommendation on the stock

Quelle: PLX AI